Main Topic Area
All Topic Areas
1 - 10 of 1012 more >>
Articles
1 - 1 of 1
- Antagon Injection Consumer Information
Antagon is used to inhibit premature ovulation in women undergoing fertility procedures. Women who have experienced a hypersensitivity reaction to gonadotropin-releasing hormone (GnRH) or any other GnRH-type drug. Women who suspect or know they are pregnant. A physician specializing in fertility treatment should prescribe Antagon. Before starting treatment with Antagon, pregnancy must be ruled out. General Precautions with Antagon: Patients with hypersensitivity to GnRH should be closely...
U.S. Food and Drug Administration
News
1 - 5 of 406 more >>
- Coke announces new labels revealing amount of caffeine per serving
The Earth Times - Fri, 23 Feb 2007 12:22 EST
- Coca-Cola to Put Caffeine Content Information on U.S. Labels
New York Times - Thu, 22 Feb 2007 03:39 EST
- Vital Signs: Childbirth: Cutting Caffeine Not Found to Affect Birth Weight
New York Times - Mon, 12 Feb 2007 10:21 EST
- Injection Drug Use Fueling Spread Of HIV In Mauritius
MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST
- Caffeine May Prevent Heart Disease Death In Elderly
MedicalNewsToday - Tue, 27 Feb 2007 03:00 EST
Clinical Trials
1 - 5 of 314 more >>
- Assessment and Treatment of Caffeine Dependence
ClinicalTrials.gov Identifier: NCT00338195 - Recruiting
Self-Identified Problematic Caffeine Use; DSM-IV Substance Dependence as Applied to Caffeine
- TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
Ovarian Neoplasms
- Penile Injection Anxiety
ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
- Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
Myocardial Infarction
- A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism

Not Signed In -

